Search

everythinglearnresearchcommunity

for

Search:↓

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.